Pharma news
Pharma
The best lawyers acting for life sciences companies make sure they fully understand their clients’ business models, said in-house counsel at Life Sciences Patent Network 2019. 26 November 2019
Pharma
Ahead of the IQPC - Life Science IP conference in London, Kevin Mooney, chairman of the rules and procedure committee at the UPC, answers pressing questions on the IP landscape post-Brexit and the future of the Europe-wide patents court project. 25 November 2019
Pharma
Swiss drug company Novartis has agreed to buy The Medicines Co for $9.7 billion, as it focuses on expanding its cardiovascular portfolio. 25 November 2019
Pharma
English law remains fit for purpose in international contracts in spite of Brexit, heard attendees at Life Sciences Patent Network Europe today, November 21. 21 November 2019
Pharma
A German individual has lost an appeal before the tribunal of the EU General Court, after his trademark registration was opposed by Merck. 21 November 2019
Pharma
The Swiss Federal Institute of Intellectual Property has failed to stop an Indian pharmaceutical and medicine wholesaler from registering the trademark ‘Swisslife Forever’ at the UK Intellectual Property Office. 19 November 2019
Americas
Switzerland-based Roche has agreed to acquire Promedior and its portfolio of molecules for serious fibrotic diseases. 19 November 2019
Pharma
The Regents of the University of Michigan have sued an optical microscope manufacturer for allegedly infringed one of its patents. 18 November 2019
Pharma
Seattle Genetics has asked the American Arbitration Association to help resolve a dispute with Daiichi Sankyo, alleging that the Japanese pharma company used its technology to create a number of drugs. 14 November 2019
Pharma
The UK BioIndustry Association has published a manifesto detailing its recommendations on how political parties can support innovation in the UK life sciences sector, ahead of the UK general election. 12 November 2019